(5) A further point in establishing the validity of screening is the demonstration of ability to reach the population at risk with the proffered tests. Thus it is quite possible that cervical cytology is a valid screening technique, but that the expected results have so far not been established because women at greatest risk of cancer of the cervix are the least likely to accept the screening invitation. In a number of studies it has been demonstrated that older women and those least socially privileged, two factors associated with enhanced risk of the disease, are proportionately poorly represented among all women screened. New approaches are needed to reach women at high risk, one of which is the taking of cervical smears by nurses visiting in their own homes women known to belong to a high risk group.
Many screening variables are continuously distributed in a skewed normal distribution pattern with no sign of a demarcation between 'normal' and 'abnormal' levels. A frequent practice, but one to which there are objections, is to take as within 'normal' the area of the distribution lying within i 2 standard deviations from the mean value for the population sample used, that is about 95% of the total distribution. In fact the term 'normal' is misleading, suggesting as it does a fixed range, whereas in reality no more can be done than define a probability. As Murphy & Abbey (1967) have pointed out in their paper 'The normal rangea common misuse', what is needed in defining normality is a knowledge of the range in disease, i.e. the distribution of values in what they term 'the population of interest'. For example, as they point out, a much lower and narrower range of leukocytosis is of interest in diagnosing acute appendicitis than in primary carcinoma of the liver. Also the level set for 'abnormal' needs to be much more sensitive in appendicitis because of the much greater medical 'penalty' if acute appendicitis is missed compared with liver carcinoma. Elveback et al. (1970) have also attacked the principle of plus or minus 2 standard deviations from the mean as a definition of 'normal' on two principal grounds: that in fact most biochemical values are not normally distributed but show important departures from a true gaussian distribution (this can to some extent be allowed for by transformation into a log-normal distribution), and that the population sample providing the basic frequency distribution usually consists of patients attending hospital, instead of a probability sample of the general population. Elveback and her co-workers claim that important findings may thus be missed. For example, the serum calcium in a patient with a parathyroid tumour could be classified as 'normal' when it should have been regarded as indicating the need for further investigation.
We are at present at a stage of experimentinig with the possibilities of collecting large amounts of laboratory information through automation. The present need seems to be for pathologists and clinicians to scrutinize together the tests that can be provided and determine which, under what conditions, provide the highest yield of relevant information. It is important to look closely at what we do not need to do, so as to be free to concentrate on what can usefully be found by screening.
Mr J D Pole (Department ofHealth andSocial Security, Alexander Fleming House, London SE])
The Cost-effectiveness ofScreening Health services are under pressure from public demand and from developing technology. There is also pressure on costs, because productivity tends to rise more slowly in services than in manufacturing industry. One way of combating this tendency is by industrializing health care as far as possible. Screening can claim all the classic advantages of the division of labour: it enables technical specialists to be substituted for professional generalists, it uses continuous or batch processes, and it makes practicable the development and use ofmechanical aids.
Economists divide resource allocation problems into the problems of priorities, or costbenefit; techniques, or cost-effectiveness; and distributionwho gets what health care.
Screening involves questions of cost-benefit as well as cost-effectiveness. Funds are budgeted by activities, not by diseases. If introducing screening for a disease reduces the costs of conventional treatment this is likely to be a medical but not a budgetary consequence.
At a physical level, screening characteristically uses a quite different mix of resources from nonscreening methods. This is one of the arguments for screeningthat, for instance, it saves doctors' time.
Equally, it is not generally possible to achieve the same level of medical care by screeiing and nonscreening methods. The whole point of screening in some cases is that it is thought to be possible to achieve better results after early diagnosis than can be achieved later by any means.
The arguments in favour of profile screening, and particularly in favour of admission profiles, are largely concerned with length of stay. Although shortening stay leads to a reduction in costs per case, it implies an increase in the average intensity of care, and may result in a rise in costs per occupied bed per day.
The law of diminishing returns probably applies to the number of tests performed in terms of the quality of diagnosis achieved. Revenue costs may be low, but the question is how many channels are justified for routine purposes. A distinction should be maintained between tests which are diagnostic in intention and those which aim at case-finding. The implications of casefinding for medical costs and priorities are much greater than those of diagnosis.
Screening by its nature cannot be cheap, but its cost can be reduced somewhat by limiting the population to which it is applied. It must be recognized, however, that there is never an absolute cut-off in terms of specific prevalence and an economic judgment is always involved. One cuts down the cost but one misses some cases. The right cut-off level is where the extra cases missed are just about not worth the money saved. As in so many areas of social policy there is some danger that resources will get diverted into services which are characteristically taken up by the less needy.
Cost information is scarce, but a reasonable estimate for an effective automated multiple screening programme up to first-stage referral might be £100-200m per annum. It is unlikely that one could find economies in other forms of case-finding and referral on an equivalent scale, so that there would be an inevitable switch of resources from treatment to case-finding. Simultaneously there would be an increased demand for treatment from the new cases found, so that the average amount of treatment resources available per case would be further reduced. The case has not been made for a switch on this scale.
Screening as case-finding involves a significant switch, not simply between techniques, but between priorities. Thorough-going screening programmes for both breast cancer and cancer of the cervix would cost about as much as, and possibly more than, the present total cost to the health service of treating these conditions. In the early years, at least until the preventive measures began to take effect, the resources devoted to these diseases might well be more than doubled, because of the costs of the early treatment, sacrificing services in perhaps quite different areas ofhealth care.
The extent to which the advantages of industrialized techniques can be claimed varies considerably among screenable conditions. The expensive screening tests are those which use a lot of labour, such as the cancer programmes. How far is it sensible to switch resources between testsfrom physical examination to biochemical testingwhen the conditions screened for may be quite different ?
The answer lies in effectiveness; in particular, the effectiveness of treatment. Unfortunately there seems to be no settled opinion among doctors on the effectiveness of several forms of screening. Medical evaluation has to precede economic evaluation. Htmoglobin and ESR were included on the general practice patients only
